12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Lannett (NYSE:LCI) shares rose 11.61% to $1.73 during Tuesday's after-market session. The market value of their outstanding shares is at $74.3 million.
Mid-Afternoon Market Update: Dow Dips 500 Points; ImmunoGen Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 1.44% to 34,628.69 while the NASDAQ fell 1.34% to 15,571.16. The S&P also fell, dropping 1.36% to 4,592.03.
Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Shares Jump
Midway through trading Tuesday, the Dow traded down 0.88% to 34,827.81 while the NASDAQ fell 0.78% to 15,659.31. The S&P also fell, dropping 0.3832% to 4,616.53.
ImmunoGen Shares Rally After Ovarian Cancer Trial Meets Primary Endpoint Goal
ImmunoGen Inc (NASDAQ: IMGN) shares have gained more than 30% during premarket trading in reaction to
SVB Leerink Maintains Market Perform on Immunogen, Lowers Price Target to $5
SVB Leerink analyst Jonathan Chang maintains Immunogen (NASDAQ:IMGN) with a Market Perform and lowers the price target from $6 to $5.
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Recap: Immunogen Q3 Earnings
Immunogen (NASDAQ:IMGN) reported its Q3 earnings results on Friday, October 29, 2021 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunogen reported in-line EPS of $-0.18 versus an estimate of $-0.18.
Immunogen Q3 EPS $(0.18), Inline, Sales $9.20M Miss $19.03M Estimate
Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 38.46 percent decrease over losses of $(0.13) per share from the same period last year. The
Earnings Scheduled For October 29, 2021
Companies Reporting Before The Bell
• Sify Technologies (NASDAQ:SIFY) is expected to report quarterly earnings at $0.02 per share on revenue of $97.70 million.
Earnings Outlook For Immunogen
Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2021-10-29. Here's what investors need to know before the announcement.
Analysts estimate that Immunogen will likely report an Earnings Per Share (EPS) of $-0.18